Dr. Julee Kim received her diploma degree in Biotechnology at the Westfaelisch Wilhelms University of Muenster in 2007. She graduated from the Westfaelisch Wilhelms University of Muenster with a Ph.D. degree in Biology at the Max Planck Institute for Molecular Biomedicine in 2013. She completed her post-doctoral training at the University of California San Francisco and at Columbia University, Irving Cancer Research Center. She worked as a research assistant professor at the University of Ulsan College of Medicine, Asan Medical Center, and as a research professor at CHA University. Currently, she is a senior researcher at the Seoul National University College of Medicine. She has 8 publications in international journals. She presented papers in more than 10 national and international conferences.
Reprogramming of stem cells, development of biomarker in cancer immunology and their application in the development of clinical model in disease treatment using stem cell- and cancer cell-targeted therapeutic strategies including stem cell transplantation, molecular-targeted therapy, stem cell-specific pathway and cancer cell-specific pathway, production of antibody and development of an in vitro system, reprogramming of pluripotent stem cells.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
